Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Products: St. Jude Renal Denervation; Zimmer Shoulder; Respicardia Sleep Apnea Pulse Generator

This article was originally published in The Gray Sheet

Executive Summary

St. Jude’s next-generation EnligHTN renal denervation system earns a CE mark. Respicardia launches First implant pulse generator to treat central sleep apnea. FDA clears Zimmer shoulder system. GeneDX launches BRCA1 and BRCA2 genetic tests not long after Supreme Court overturns Myriad’s monopoly on the tests.

Advertisement

Related Content

St. Jude Halts U.S. Renal Denervation Trial, Citing Slow Patient Enrollment
Medtronic Renal Denervation System Provides Durable Blood Pressure Benefits In Longest Trial To Date
Myriad Wields Proprietary Database To Protect Testing Market
Research In Brief

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT032375

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel